Bio Essence (BIOE) Shares Outstanding (Weighted Average) (2020 - 2026)

Bio Essence's Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $45.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 18.26% year-over-year to $45.0 million; the TTM figure through Mar 2026 stood at $45.0 million (up 18.26% YoY), while the FY2025 annual figure was $38.0 million, changed 0.0% from the prior year.
• Shares Outstanding (Weighted Average) was $45.0 million for Q1 2026 at Bio Essence, up from $38.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $45.0 million in Q1 2026 to a low of $33.0 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $36.3 million across 5 years, with a median of $38.0 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) changed 0.0% in 2022, then climbed 18.26% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $33.0 million in 2022, then grew by 2.86% to $34.0 million in 2023, then advanced by 11.94% to $38.0 million in 2024, then changed by 0.0% to $38.0 million in 2025, then increased by 18.26% to $45.0 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $45.0 million (Q1 2026), $38.0 million (Q4 2025), and $38.0 million (Q3 2025), per Business Quant data.